Jeffrey Zabinski, MD, MSW, is an Assistant Professor of Psychiatry at Columbia University Irving Medical Center, where he leads the ketamine treatment program within the interventional psychiatry services. He is an expert in psychotherapy and psychopharmacology for patients with difficult to treat and medically complex psychiatric illnesses.

Dr. Zabinski has played a pivotal role in the launch and expansion of intranasal esketamine and IV ketamine services, and previously was the inaugural liaison to neurology and neurosurgery. His professional interests include neuropsychiatry, delirium, medical ethics, interventional psychiatry, and psychedelics. He has also completed psychedelic psychotherapy training programs that inform his compassionate, interdisciplinary approach. Beyond his clinical and research contributions, Dr. Zabinski is a dedicated educator and mentor to medical students, residents, fellows, and graduate students. He is a recipient of the Leonard Tow Humanism in Medicine Award, a member of the expert faculty of ASKP3, and a previous Webb Fellow in the ACLP.

Dr. Zabinski's diverse academic background includes a BSE in biomedical engineering, an MA in bioethics, and an MSW. He completed clinical training at Johns Hopkins Hospital for residency, where he served as Chief Resident, followed by a fellowship in consultation liaison psychiatry at NYU before joining the faculty at Columbia.